These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2303788)

  • 21. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice.
    Schirmbeck R; Zerrahn J; Kuhröber A; Kury E; Deppert W; Reimann J
    Eur J Immunol; 1992 Mar; 22(3):759-66. PubMed ID: 1312473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen.
    Romani L; Mage MG
    Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of I-region associated antigen (Ia)-bearing accessory cells in the generation of cytotoxic T cells in a subpopulation of thymocytes.
    Okuno K; Kikuchi Y; Tsuchida T; Hamaoka T; Igarashi T; Kato R; Takatsu K
    Jpn J Cancer Res; 1986 Jul; 77(7):711-21. PubMed ID: 3091558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
    Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
    Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses.
    De Bruijn ML; Nieland JD; Schumacher TN; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1992 Nov; 22(11):3013-20. PubMed ID: 1425925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
    Williams FH; Thiele DL
    Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?
    Takahashi H; Nakagawa Y; Leggatt GR; Ishida Y; Saito T; Yokomuro K; Berzofsky JA
    J Exp Med; 1996 Mar; 183(3):879-89. PubMed ID: 8642292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule.
    Song ES; Linsk R; Olson CA; McMillan M; Goodenow RS
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1927-31. PubMed ID: 3258067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH; Miller RG
    J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
    Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
    Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combination of soluble helper factors bypasses the requirement for stimulator cells and induces nonspecific cytotoxic T cell responses.
    Männel DN; Dröge W; Falk W
    Immunobiology; 1985 Sep; 170(3):146-57. PubMed ID: 2414210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
    Mangino G; Grazia Capri M; Barnaba V; Alberti S
    Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of alloantigen by cytotoxic T cell precursors is independent of the function of Ia+ cells.
    Iwasaki H; Taniguchi M; Shinohara N
    J Immunol; 1985 Jun; 134(6):3592-6. PubMed ID: 3872900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells.
    Forquet F; Calin V; Trescol-Biemont MC; Kanellopoulos J; Mottez E; Kourilsky P; Rabourdin-Combe C; Gerlier D
    Eur J Immunol; 1990 Oct; 20(10):2325-32. PubMed ID: 2242761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Priming antiviral cytotoxic T lymphocytes: requirement for CD4+ cells is dependent on the antigen presenting cell in vivo.
    Ciavarra RP; Tedeschi B
    Cell Immunol; 1994 Aug; 157(1):132-43. PubMed ID: 7913664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.